Aytu BioPharma, Inc. (AYTU) Financials

AYTU Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 131.2 million 98.4 million
2023-09-30 136.5 million 97.1 million
2023-06-30 136.5 million 97.1 million
2023-03-31 147.2 million 106.3 million

AYTU Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 -135000 820000
2023-09-30 9.4 million 900000
2023-06-30 9.4 million 900000
2023-03-31 -2.9 million 902000

AYTU Net Income

No data available :(

AYTU Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 19.5 million - -
2023-09-30 23.0 million - -
2023-06-30 - - -
2023-03-31 19.2 million - -

AYTU Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 5.5 million
2023-09-30 4.1 million
2023-06-30 5.5 million
2023-03-31 3.7 million

AYTU Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 - 524000 5.4 million 6.6 million
2023-09-30 - 465000 6.1 million 8.0 million
2023-06-30 - 465000 14.1 million -
2023-03-31 - 856000 7.2 million 12.8 million

AYTU Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 22.9 million 6.7 million
2023-09-30 30.7 million 12.2 million
2023-06-30 30.7 million 12.2 million
2023-03-31 22.7 million 10.0 million

AYTU

Price: $2.90

52 week price:
1.38
3.50

Earnings Per Share: -4.01 USD

P/E Ratio: -0.45

Exchange: NCM

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Volume: 55600

Ebitda: -9.2 million

Market Capitalization: 17.9 million

Links: